vs
Healthpeak Properties(DOC)与SelectQuote, Inc.(SLQT)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是SelectQuote, Inc.的1.3倍($719.4M vs $537.1M),Healthpeak Properties净利率更高(73.2% vs 12.9%,领先60.3%),SelectQuote, Inc.同比增速更快(11.6% vs 3.1%),Healthpeak Properties自由现金流更多($357.0M vs $-1.0M),过去两年SelectQuote, Inc.的营收复合增速更高(19.5% vs 8.9%)
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
SelectQuote是面向消费者的直售平台,主营保险产品与医疗服务业务,通过对接消费者与保险机构获取佣金,覆盖长者健康险、人寿险、车险、家财险等品类,医疗服务板块以认证药房SelectRx为核心业务,公司于2020年5月上市。
DOC vs SLQT — 直观对比
营收规模更大
DOC
是对方的1.3倍
$537.1M
营收增速更快
SLQT
高出8.6%
3.1%
净利率更高
DOC
高出60.3%
12.9%
自由现金流更多
DOC
多$358.0M
$-1.0M
两年增速更快
SLQT
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $719.4M | $537.1M |
| 净利润 | $114.0M | $69.3M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 17.4% | 14.0% |
| 净利率 | 73.2% | 12.9% |
| 营收同比 | 3.1% | 11.6% |
| 净利润同比 | 2406.4% | 30.2% |
| 每股收益(稀释后) | $0.16 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOC
SLQT
| Q4 25 | $719.4M | $537.1M | ||
| Q3 25 | $705.9M | $328.8M | ||
| Q2 25 | $694.3M | $345.1M | ||
| Q1 25 | $702.9M | $408.2M | ||
| Q4 24 | $698.0M | $481.1M | ||
| Q3 24 | $700.4M | $292.3M | ||
| Q2 24 | $695.5M | $307.2M | ||
| Q1 24 | $606.6M | $376.4M |
净利润
DOC
SLQT
| Q4 25 | $114.0M | $69.3M | ||
| Q3 25 | $-117.1M | $-30.5M | ||
| Q2 25 | $31.7M | $12.9M | ||
| Q1 25 | $42.8M | $26.0M | ||
| Q4 24 | $4.5M | $53.2M | ||
| Q3 24 | $85.9M | $-44.5M | ||
| Q2 24 | $146.0M | $-31.0M | ||
| Q1 24 | $6.7M | $8.6M |
毛利率
DOC
SLQT
| Q4 25 | — | 61.8% | ||
| Q3 25 | 58.6% | 41.4% | ||
| Q2 25 | 60.2% | 47.2% | ||
| Q1 25 | 61.1% | 60.2% | ||
| Q4 24 | 60.3% | 67.5% | ||
| Q3 24 | 60.0% | 55.7% | ||
| Q2 24 | 60.6% | 60.7% | ||
| Q1 24 | 59.8% | 71.8% |
营业利润率
DOC
SLQT
| Q4 25 | 17.4% | 14.0% | ||
| Q3 25 | 9.2% | -12.4% | ||
| Q2 25 | 5.7% | -3.6% | ||
| Q1 25 | 7.7% | 5.4% | ||
| Q4 24 | -2.2% | 14.7% | ||
| Q3 24 | 14.1% | -4.1% | ||
| Q2 24 | 22.3% | -0.5% | ||
| Q1 24 | 3.7% | 8.8% |
净利率
DOC
SLQT
| Q4 25 | 73.2% | 12.9% | ||
| Q3 25 | -16.6% | -9.3% | ||
| Q2 25 | 4.6% | 3.7% | ||
| Q1 25 | 6.1% | 6.4% | ||
| Q4 24 | 0.7% | 11.1% | ||
| Q3 24 | 12.3% | -15.2% | ||
| Q2 24 | 21.0% | -10.1% | ||
| Q1 24 | 1.1% | 2.3% |
每股收益(稀释后)
DOC
SLQT
| Q4 25 | $0.16 | $0.26 | ||
| Q3 25 | $-0.17 | $-0.26 | ||
| Q2 25 | $0.05 | $-0.06 | ||
| Q1 25 | $0.06 | $0.03 | ||
| Q4 24 | $0.02 | $0.30 | ||
| Q3 24 | $0.12 | $-0.26 | ||
| Q2 24 | $0.21 | $-0.17 | ||
| Q1 24 | $0.01 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $18.3M |
| 总债务越低越好 | $9.8B | $405.8M |
| 股东权益账面价值 | $7.5B | $359.7M |
| 总资产 | $20.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.31× | 1.13× |
8季度趋势,按日历期对齐
现金及短期投资
DOC
SLQT
| Q4 25 | $467.5M | $18.3M | ||
| Q3 25 | $91.0M | $10.7M | ||
| Q2 25 | $89.4M | $32.4M | ||
| Q1 25 | $70.6M | $80.1M | ||
| Q4 24 | $119.8M | $7.3M | ||
| Q3 24 | $180.4M | $10.4M | ||
| Q2 24 | $106.9M | $42.7M | ||
| Q1 24 | $101.8M | $37.8M |
总债务
DOC
SLQT
| Q4 25 | $9.8B | $405.8M | ||
| Q3 25 | $9.1B | $393.1M | ||
| Q2 25 | $9.0B | $385.1M | ||
| Q1 25 | $8.9B | $391.5M | ||
| Q4 24 | $8.7B | $711.9M | ||
| Q3 24 | $8.6B | $680.4M | ||
| Q2 24 | $8.6B | $683.3M | ||
| Q1 24 | $8.8B | $686.0M |
股东权益
DOC
SLQT
| Q4 25 | $7.5B | $359.7M | ||
| Q3 25 | $7.6B | $305.1M | ||
| Q2 25 | $7.9B | $351.1M | ||
| Q1 25 | $8.2B | $350.2M | ||
| Q4 24 | $8.4B | $326.0M | ||
| Q3 24 | $8.6B | $269.4M | ||
| Q2 24 | $8.8B | $316.8M | ||
| Q1 24 | $8.9B | $346.8M |
总资产
DOC
SLQT
| Q4 25 | $20.3B | $1.4B | ||
| Q3 25 | $19.6B | $1.2B | ||
| Q2 25 | $19.8B | $1.2B | ||
| Q1 25 | $19.8B | $1.3B | ||
| Q4 24 | $19.9B | $1.3B | ||
| Q3 24 | $20.0B | $1.1B | ||
| Q2 24 | $20.2B | $1.2B | ||
| Q1 24 | $20.5B | $1.2B |
负债/权益比
DOC
SLQT
| Q4 25 | 1.31× | 1.13× | ||
| Q3 25 | 1.20× | 1.29× | ||
| Q2 25 | 1.14× | 1.10× | ||
| Q1 25 | 1.08× | 1.12× | ||
| Q4 24 | 1.04× | 2.18× | ||
| Q3 24 | 1.00× | 2.53× | ||
| Q2 24 | 0.98× | 2.16× | ||
| Q1 24 | 0.99× | 1.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.3B | $52.0K |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $-1.0M |
| 自由现金流率自由现金流/营收 | 49.6% | -0.2% |
| 资本支出强度资本支出/营收 | 124.4% | 0.2% |
| 现金转化率经营现金流/净利润 | 10.99× | 0.00× |
| 过去12个月自由现金流最近4个季度 | — | $8.5M |
8季度趋势,按日历期对齐
经营现金流
DOC
SLQT
| Q4 25 | $1.3B | $52.0K | ||
| Q3 25 | $315.0M | $-21.6M | ||
| Q2 25 | $363.5M | $-37.5M | ||
| Q1 25 | $279.4M | $71.1M | ||
| Q4 24 | $1.1B | $-28.7M | ||
| Q3 24 | $318.2M | $-16.6M | ||
| Q2 24 | $316.2M | $20.0M | ||
| Q1 24 | $152.6M | $44.5M |
自由现金流
DOC
SLQT
| Q4 25 | $357.0M | $-1.0M | ||
| Q3 25 | — | $-22.7M | ||
| Q2 25 | — | $-38.0M | ||
| Q1 25 | — | $70.2M | ||
| Q4 24 | $333.7M | $-29.0M | ||
| Q3 24 | — | $-17.1M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $43.4M |
自由现金流率
DOC
SLQT
| Q4 25 | 49.6% | -0.2% | ||
| Q3 25 | — | -6.9% | ||
| Q2 25 | — | -11.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | 47.8% | -6.0% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | 6.4% | ||
| Q1 24 | — | 11.5% |
资本支出强度
DOC
SLQT
| Q4 25 | 124.4% | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 105.6% | 0.1% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.3% |
现金转化率
DOC
SLQT
| Q4 25 | 10.99× | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | -2.91× | ||
| Q1 25 | 6.52× | 2.73× | ||
| Q4 24 | 235.43× | -0.54× | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | 5.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |